BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the FirmBusiness Wire • 11/04/23
The Law Offices of Frank R. Cruz Announces Investigation of Brainstorm Cell Therapeutics Inc. (BCLI) on Behalf of InvestorsBusiness Wire • 11/03/23
BRAINSTORM SHAREHOLDER ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Brainstorm To Contact Him Directly To Discuss Their OptionsPRNewsWire • 11/03/23
NATIONALLY RANKED ROSEN LAW FIRM Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BCLIPRNewsWire • 11/03/23
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. – BCLIBusiness Wire • 11/01/23
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Brainstorm Cell Therapeutics Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 10/30/23
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALSPRNewsWire • 10/24/23
BrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALSPRNewsWire • 10/18/23
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Brainstorm Cell Therapeutics Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 10/18/23
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Brainstorm Cell Therapeutics Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 10/12/23
ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLIPRNewsWire • 10/07/23
BCLI LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLIPRNewsWire • 09/29/23
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation – BCLIBusiness Wire • 09/28/23
BrainStorm shares plunge 56% after FDA advisers reject ALS cell therapyProactive Investors • 09/28/23
Brainstorm Cell Therapeutics shares fall more than 50% after FDA advisors vote down ALS treatmentMarket Watch • 09/28/23
BrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALSPRNewsWire • 09/28/23
BrainStorm Cell shares fall as FDA reviewers raise doubts over effectiveness of ASL therapyProactive Investors • 09/25/23
Brainstorm Cell Therapeutics: I Anticipate A Positive AdCom But There Are Major RisksSeeking Alpha • 09/15/23
BrainStorm Cell Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate UpdatePRNewsWire • 08/14/23
BrainStorm to Announce Second Quarter 2023 Financial Results and Provide a Corporate UpdatePRNewsWire • 08/07/23